Cambridge Investment Research Advisors, Inc. Tarsus Pharmaceuticals, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 23,150 shares of TARS stock, worth $960,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,150
Previous 23,175
0.11%
Holding current value
$960,725
Previous $1.28 Million
7.33%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TARS
# of Institutions
200Shares Held
44.1MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$138 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$136 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$108 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$103 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$102 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.11B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...